How to buy Novo Nordisk shares in 2025

Novo Nordisk A/S ($NVO) is a leading global healthcare company specialising in diabetes care and other serious chronic diseases.

👉 Read on to learn about Novo Nordisk and how to buy $NVO shares in a few easy steps.

Stock cards hero
NVO logo

NVO

NVO logo

NVO

NVO logo

NVO

NVO logo

NVO

NVO logo

NVO

NVO logo

NVO

NVO logo

NVO

NVO logo

NVO

NVO logo

NVO

NVO logo

NVO

How to buy Novo Nordisk stock in 5 steps

When investing in shares - whether NVO or otherwise - it’s important to consider your financial position, investing goals and risk tolerance. Before making any investment decision, it’s wise to consider your current circumstances and consult with a financial planner or advisor. If you decide that investing in Novo Nordisk is right for you, then consider the following steps.

1. Open an investing account

To buy Novo Nordisk stock in Australia, you’ll need to sign up to an investing platform with access to the U.S. share market. Stake offers seamless access to 12,000+ stocks and ETFs across the U.S. and Australian markets, including NVO.

2. Fund your account

Once you’ve opened an account, you’ll need to deposit funds to allow you to buy NVO shares. With Stake, you can deposit via bank transfer, debit/credit card, Apple Pay, Google Pay or set up a recurring deposit using PayTo.

Sign up to invest in NVO stock

Open an account
Stake app pictured on tilted phone screen
3. Search for Novo Nordisk or NVO

Find your prospective investment by searching the name or ticker symbol of the company. If you’re using Stake, you can easily search on our web trading platform or the Stake app.

4. Place an order for NVO shares

The next step is to place an order for the number of Novo Nordisk shares you’d like to buy. Be sure to check the market is open and ensure the order type and volume align with your investment plan.

5. Monitor your investment

Once your order executes, you should keep an eye on the company’s performance and monitor the performance of your portfolio. Check regularly to ensure your investment is aligned with your financial goals.

Put it on repeat?

If you intend to regularly purchase NVO shares, you could consider setting up a recurring investment. On Stake, you can set up a consistent purchase order for Novo Nordisk shares which may be useful if you’re thinking of investing in the company over the long term.


Novo Nordisk company overview

Novo Nordisk is a leader in diabetes care, focusing on innovation in insulin products and other related healthcare treatments. The company also invests in treatments for obesity and rare blood disorders, consistently driving growth through medical advancements.


Novo Nordisk share price performance

The Novo Nordisk share price was US$78.79 (-3.45%) as of market close.

Key metrics for Novo Nordisk

Get a breakdown of Novo Nordisk’s financial metrics.

Latest market closeUS$78.79
Market capitalisationUS$269.73B
PE Ratio25.07
Earnings per shareUS$3.14
Day change-3.45%
52-week highUS$148.15
52-week lowUS$73.80

Data updated as of March 21, 2025.

Schedule a recurring investment in Novo Nordisk

Put your favourites on repeat - like Novo Nordisk - with a recurring investment on Stake. It’s a great way to build towards long-term goals and a convenient method to stay consistent with your investing habits.
You’re always in control, it’s easy to hit pause or skip a scheduled order.

Set up a recurring $NVO investment
Recurring investment image

Does Novo Nordisk pay dividends?

Yes, Novo Nordisk pays dividends.

Dividend yield2.05%

Data updated as of March 21, 2025.

Dividend up arrow

What is the Novo Nordisk price target?

The average price target for NVO is US$132.5 across 2 combined analyst ratings.

The suggestion is to BUY with 100% of analysts suggesting to buy, 0% suggest hold and 0% suggest sell.

Analyst ratings and price targets are provided for informational purposes by our market data partner, Benzinga, and do not constitute a recommendation to make an investment decision. Future forecasts are not a reliable indicator of future performance.

Analyst ratings in Stake app

How to sell Novo Nordisk shares?

The process of selling Novo Nordisk shares on Stake is similar to purchasing them. If you already own NVO shares on the platform and looking to sell, follow these steps:

  1. Open Stake, head to your Holdings and find Novo Nordisk
  2. Select Sell
  3. Choose the order type, number of shares/dollar value and the desired price (if applicable)
  4. Review your Sell order
  5. Follow the prompts to submit your order

Watch this video to see just how simple it is to buy and sell shares on Stake.

Is it a good time to buy Novo Nordisk shares?

Like any investment, Novo Nordisk may be a suitable option for some, but not for others. It’s important to understand that investing in any financial instrument comes with a certain level of risk.

You should always conduct your own research and consider your personal financial circumstances before buying $NVO shares. When researching, consider the company’s financial health, future prospects, current market conditions and whether or not it aligns with your investment strategy.

What are some similar stocks to NVO?

Eli Lilly and Company ($LLY): A global pharmaceutical company, similar to Novo Nordisk, with a focus on treatments for chronic diseases. Sanofi ($SNY): Specializes in diabetes care and pharmaceuticals, directly competing with Novo Nordisk. Pfizer ($PFE): Another key player in the pharmaceutical industry, known for its innovation in healthcare products, like Novo Nordisk.

What are some ETFs that hold NVO?

iShares Global Healthcare ETF ($IXJ): This ETF includes Novo Nordisk as it focuses on large healthcare companies worldwide, specializing in pharmaceuticals and biotechnology. SPDR S&P Pharmaceuticals ETF ($XPH): Novo Nordisk is a holding in this ETF due to its leading role in pharmaceutical development, particularly in diabetes care. Vanguard Health Care ETF ($VHT): This ETF holds Novo Nordisk as part of its focus on major players in the healthcare industry, especially those involved in chronic disease treatments.

Why invest on Stake?

Join 500k+ ambitious investors on a powerful yet easy-to-use trading platform.

Invest in Novo Nordisk for as little as US$10

Own a slice of the world’s biggest stocks like Novo Nordisk, investing as little as US$10.

12,000+ global opportunities

Hold AUD and USD and glide between Aussie and U.S. markets with just a tap.

Simple fees

$3 brokerage on all trades up to $30,000, whether it’s Wall St or the ASX.

Extended Hours on Wall St

An additional 9.5 hours of Wall St access per trading day, so you can react faster.

Open an account

Novo Nordisk Common Questions

If you’re new to the investing world, it’s always wise to get educated on the fundamentals of the market. Luckily you can learn all about it free of charge at our learning hub, Stake Academy. If you decide that Novo Nordisk aligns with your financial goals, then follow these steps:
  1. Sign up to Stake on desktop or via the Stake app
  2. Activate Stake wall-st
  3. Deposit funds via bank transfer, credit/debit card, Apple Pay/Google Pay or PayTo
  4. Place a buy order for Novo Nordisk
  5. Monitor your investment

With Stake Wall St, you can start investing in U.S. companies like Novo Nordisk with as little as US$10 thanks to fractional shares.

Fractional shares allow U.S. investors to purchase a portion of a share in lieu of an entire stock. This can be advantageous for some investors who seek to hold a company in their portfolio but don’t want to pay for a full share.

So, in the case of Novo Nordisk, you could buy in with as little as US$10 instead of paying for a full share which was valued at US$76.07 at last market close.

Whether or not Novo Nordisk is a good buy is dependent on your investing goals, strategy and risk tolerance. It’s essential to conduct thorough research on Novo Nordisk and decide whether you believe it to be a sound investment that aligns with your financial goals.

Novo Nordisk typically reports earnings on a quarterly basis. For exact dates, it's best to check Novo Nordisk's investor relations page for any adjustments to the schedule​.

Lars Fruergaard Jørgensen is the CEO of Novo Nordisk, having assumed the position in January 2017. He has guided the company through its continued focus on diabetes and obesity treatments, positioning Novo Nordisk as a leader in biopharmaceuticals.

Stake app download banner

Take control of your financial future

Build your wealth seamlessly with Stake.
Download on the App StoreGet it on Google Play

This is for information purposes only and is not a recommendation to invest in the securities listed. Such information is not intended to constitute financial advice and no agency or advisory relationship is created between you and Stake as a result of having access to or using the Information. This information does not take into account your personal objectives, financial situation or needs. You agree that neither Stake nor any third party provider is responsible for any investment decisions or for any damages or other losses resulting from the use of the Information. As always, do your own research before making any investment decisions and consider seeking advice from a licensed financial adviser. No representation or warranty is made as to the timeliness, reliability, accuracy or completeness of the material and Stake does not accept any responsibility arising from errors in, or omissions from, the data. Past performance is not a reliable indicator of future performance.


Stake logo
Over 7,000 5-star reviews
App Store logoGoogle Play logo

Subscribe to our free newsletters

By subscribing, you agree to our Privacy Policy.

Stakeshop Pty Ltd, trading as Stake, ACN 610 105 505, is an authorised representative (Authorised Representative No. 1241398) of Stakeshop AFSL Pty Ltd (Australian Financial Services Licence no. 548196). Stake SMSF Pty Ltd ACN 648 283 532 (‘Stake Super’) is not licensed to provide financial product advice under the Corporations Act. This specifically applies to any financial products which are established if you instruct Stake Super to set up a self managed super fund (‘SMSF’). When you sign up to Stake Super, you are contracting with Stake SMSF Pty Ltd who will assist in the establishment of a SMSF under a ‘no advice model’. You will also be referred to Stakeshop Pty Ltd to enable your trading account and bank account to be set up in order to use the Stake Website and/or App. For more information about SMSFs, see our SMSF Risks page. The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake and Stake Super, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Any advice given by Stake is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Please view our Financial Services GuideTerms & ConditionsPrivacy Policy and Disclaimers before deciding to invest on or use Stake or Stake Super. By using our website or service in any way, you agree to our Privacy Policy and Terms & Conditions. All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake and Stake Super are registered trademarks in Australia.

Copyright © 2025 Stake. All rights reserved.